Taiwan FDA registration 75822794612f9d777d01037f4c8435ff
HighQ Check Pro Blood Glucose Monitoring System
TW: 長青宜測血糖監測系統
Taiwan·Risk Class 2·MD·AEON DIAGNOSTIC TECHNOLOGY CORPORATION·Registered May 15, 2020 – Nov 06, 2023ExpiredRegistration details
- Analysis ID
- 75822794612f9d777d01037f4c8435ff
- License Form
- Ministry of Health Medical Device Manufacturing No. 006710
Company information
- Manufacturer
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is only for in vitro testing, which can quantitatively detect the blood glucose value of fingertip microvascular whole blood, and is not suitable for neonatal testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- May 15, 2020
- Expiry Date
- Nov 06, 2023
About this record
Access comprehensive regulatory information for HighQ Check Pro Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 75822794612f9d777d01037f4c8435ff and manufactured by AEON DIAGNOSTIC TECHNOLOGY CORPORATION. The authorized representative in Taiwan is AEON DIAGNOSTIC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices